◆ Diabetes Obesity and Metabolism2026-01-20· Medicine
Is the combination of resmetirom and semaglutide useful for the treatment of metabolic dysfunction‐associated steatohepatitis?
Stergios A. Polyzos, Jannis Kountouras, Leonidas H. Duntas, Giovanni Targher
原始摘要（英文原文）· Original abstract
The authors have no conflicts of interest to declare. The peer review history for this article is available at https://www.webofscience.com/api/gateway/wos/peer-review/10.1111/dom.70507. Data sharing is not applicable to this article, as no datasets were generated or analysed during the preparation of this Commentary.